Adma Biologics (ADMA) Gross Profit (QoQ) (2012 - 2025)
Adma Biologics (ADMA) Gross Profit (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.44% |
| Sep 30, 2025 | 12.49% |
| Jun 30, 2025 | 10.03% |
| Mar 31, 2025 | -3.53% |
| Dec 31, 2024 | 6.16% |
| Sep 30, 2024 | 3.84% |
| Jun 30, 2024 | 46.91% |
| Mar 31, 2024 | 25.81% |
| Dec 31, 2023 | 26.09% |
| Sep 30, 2023 | 47.71% |
| Jun 30, 2023 | 1.07% |
| Mar 31, 2023 | 16.48% |
| Dec 31, 2022 | 46.81% |
| Sep 30, 2022 | 24.29% |
| Jun 30, 2022 | 112.16% |
| Mar 31, 2022 | 4.30% |
| Dec 31, 2021 | 811.20% |
| Sep 30, 2021 | 138.46% |
| Jun 30, 2021 | 41.79% |
| Mar 31, 2021 | 66.61% |